These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2908264)

  • 1. [Evaluation of the effectiveness and tolerance of broxaterol in 10 patients with reversible bronchospasm].
    Scoditti S; Paladini A; Stomeo S; Toma P; Aversa C
    Arch Monaldi Mal Torace; 1987; 42(4):383-8. PubMed ID: 2908264
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness of a new beta 2-agonist (broxaterol) on bronchospasm induced by methacholine (blind study versus salbutamol)].
    Corrias A; Corona GB; Pelosi U; Corda R
    Pediatr Med Chir; 1989; 11(1):61-3. PubMed ID: 2566160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the effectiveness and tolerance of a new beta-2 stimulant (broxaterol) vs. salbutamol in patients with chronic obstructive bronchopneumopathy].
    Giosuè S; Guerrini P; Cafaggi R; D'Onofrio V; Perrone N; Scano M
    Clin Ter; 1987 Apr; 121(1):35-9. PubMed ID: 2885123
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of broxaterol in bronchial hyperresponsiveness.
    Bianco S
    Respiration; 1989; 55 Suppl 2():20-7. PubMed ID: 2572037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broxaterol (Z.1170), a new oral beta 2-agonist compared with salbutamol.
    Perruchoud AP; Bründler H; Godly R; Imhof E; Herzog H
    Respiration; 1987; 51(2):113-8. PubMed ID: 2884706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negligible metabolic effects of long-term oral treatment with a new beta 2-agonist: broxaterol.
    Petraglia A; Scarpitta M; Ansalone D; Gurrieri G; Galzerano V; Calvanese RC; Federico S; Zinno A
    Int J Clin Pharmacol Res; 1990; 10(5):299-304. PubMed ID: 1981879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative evaluation of the protective effect of broxaterol and salbutamol in bronchial spasm induced with an ultrasonic aerosol of distilled water].
    De Francesca F; Grembiale RD; Bova G; Pelaia G; Tranfa CM; Marsico SA
    Arch Monaldi; 1985; 40(3-4):111-22. PubMed ID: 3842058
    [No Abstract]   [Full Text] [Related]  

  • 8. Early bronchodilating effect of a new oral beta-2-receptor agonist (broxaterol) in bronchial asthma.
    Chetta A; Garavaldi G; Cuomo A; Gurrieri G; Olivieri D
    Respiration; 1988; 53(4):220-4. PubMed ID: 2902671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Protective action of broxaterol in bronchial spasm induced by ultrasonic mist].
    Aversa C; Scorrano F; Scoditti S; Pancosta G; Stomeo S
    Arch Monaldi Mal Torace; 1988; 43(3):243-8. PubMed ID: 2908378
    [No Abstract]   [Full Text] [Related]  

  • 10. Broxaterol: a new beta2-adrenoceptor agonist for the treatment of reversible airways disease. Proceedings of the satellite symposium. Budapest, September 8, 1988.
    Respiration; 1989; 55 Suppl 2():1-44. PubMed ID: 2572034
    [No Abstract]   [Full Text] [Related]  

  • 11. [Usefulness of new beta 2 stimulant drugs on bronchospasm].
    Palomar Aranzubia FP; Alcoba Almecija MC
    Rev Clin Esp; 1977 Jun; 145(5):329-34. PubMed ID: 17886
    [No Abstract]   [Full Text] [Related]  

  • 12. Broxaterol: a double-blind clinical trial comparing broxaterol and salbutamol.
    Rampulla C; Corsico R; Majani U; Lodola E
    Respiration; 1985; 47(4):299-302. PubMed ID: 2861630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broxaterol: therapeutic trials and safety profile.
    Ziment I
    Respiration; 1989; 55 Suppl 2():28-40. PubMed ID: 2572038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indications for beta-adrenergic drugs in the treatment of respiratory insufficiency.
    Brouet G; Ruff F
    Minerva Med; 1976 Mar; 67(15):926-9. PubMed ID: 4749
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ventilatory and other effects of Sch 1000 aerosol in 54 patients with reversible bronchospasm].
    Minette A; Marcq M; Bruninx M; Spaas B; Van Hove G
    Rev Inst Hyg Mines (Hasselt); 1973; 28(1):22-38. PubMed ID: 4150623
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current evaluation of beta-adrenergic agents in the treatment of bronchial spasm].
    Cornia G; Mannino F; Pasqua F; Giammarruto R; Mariotta S
    Minerva Med; 1975 Nov; 66(77):4056-8. PubMed ID: 241949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of broxaterol in asthmatic children].
    Flores D'Arcais A; Crippa L; De Biase D; Romagnoni G
    Minerva Pediatr; 1992 Sep; 44(9):421-5. PubMed ID: 1361960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COPD and beta-blockers.
    Segal MS; MacDonnell KF
    Compr Ther; 1982 Sep; 8(9):3-5. PubMed ID: 6128100
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase I study of acivicin in patients with advanced cancer.
    Sridhar KS; Ohnuma T; Chahinian AP; Holland JF
    Cancer Treat Rep; 1983; 67(7-8):701-3. PubMed ID: 6871885
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fenoterol in the diagnosis and treatment of reversible bronchospasm].
    Sevieri GP; Quartieri F; Del Bono N
    Clin Ter; 1981 Dec; 99(6):615-22. PubMed ID: 7333073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.